Qiagen (QGEN) Tops Q2 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
QIAGEN Reports Full Results for Q2 and H1 2021
July 29, 2021 4:14 PM EDTQ2 2021 results in line with preliminary announcement: Net sales up 28% (+24% CER) to $567.3 million; adjusted diluted EPS up 22% to $0.67 ($0.66 CER) Very strong non-COVID product group sales: +52% CER growth in Q2 2021 to $407.6 million, representing 72% of total sales, expect at least 20% CER full-year growth Excellent cash flow results: H1 2021 operating cash flow rises 89% to $285.0 million and free cash flow up 94% to $195.0 million Full-year 2021 outlook for at least 12% CER sales growth and at least $2.42 CER adjusted diluted EPS (as announced on July... More
